Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01769 |
| Species: | Homo sapiens |
| Position : | chr6:28895115-28896348 |
| Year: | 2023 |
| Title: | High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Burkitt lymphoma |
| PMID: | 37591883 |
| MONDO: | MONDO:0002483 |
| Tissue: | Lymph node |
| Tissue Ontology ID: | UBERON:0000029 |
| Cell Source: | Namalwa (B-lymphocyte) |
| CVCL ID: | CVCL_0128 |
| Cell Type: | Burkitt lymphoma cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Enhancer identification, Transcriptional regulation assay |
| High Throughput Method: | HiS-NET-seq, ChIP-Rx, GRO-cap |
| Low Throughput Method: | Dual-luciferase reporter assay |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|